Patent ID: 11872225
Assignee: AGIOS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 3:
4. The method of claim 1, wherein the compound is of Formula (II):, , or a pharmaceutically acceptable salt thereof, wherein:
Ra and Rb are each independently hydrogen, halogen, —CN, —NO2, —N3, optionally substituted alkyl, —ORo3, —N(Rn1)2, —C(═O)N(Rn1)2, or —C(═O)Rc2, or Ra and Rb can be taken together with the carbon atom to form optionally substituted cycloalkyl or optionally substituted heterocyclyl;
each instance of Rn1 is independently hydrogen, optionally substituted —C1-C6 alkyl, or a nitrogen protecting group;
each instance of Ro3 is independently hydrogen, optionally substituted —C1-C6 alkyl, or an oxygen protecting group; and
each instance of Rc2 is independently optionally substituted —C1-C6 alkyl.